「0.1%and」の検索結果
99件：56～60件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf -
Milestones in Our History | About Senju | SENJU Pharmaceutical
1947 Apri Hiroshi Tsuzuki (CEO) established the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 Feb
https://www.senju.co.jp/english/about/history.html -
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708_0.pdf -
General Announcement: December 2, 2022 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “MIEr-Blue” and “MIEr-Red” Senju Pharmaceutical Co., Ltd. hereby announces the commercial launch and dis
https://www.senju.co.jp/sites/default/files/content_news/2022-11/ENG_20221202.pdf -
General Announcement: December 2, 2022 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “MIEr-Blue” and “MIEr-Red” Senju Pharmaceutical Co., Ltd. hereby announces the commercial launch and dis
https://www.senju.co.jp/sites/default/files/content_news/2022-11/ENG_20221202_0.pdf